If someone is already using semaglutide but has stopped losing weight, the best option may not be switching to a different GLP 1 like tirzepatide or retatrutide. Instead, adding cagrilintide, a Cagrilintide Lumin Peptides Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit CagriSema (Cagrilintide + Semaglutide) and Retatrutide are highly effective for weight loss, but differ in mechanisms. CagriSema combines amylin and GLP 1 effects, enhancing appetite suppression and Cagrilintide Semaglutide Blend 5mg 5mg Heritage Labs USA Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed